- Home
- SANA vs IART Comparison
SANA vs IART Comparison
Compare SANA & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANA
- IART
- Stock Information
- Founded
- SANA 2018
- IART 1989
- Country
- SANA United States
- IART United States
- Employees
- SANA N/A
- IART N/A
- Industry
- SANA Medicinal Chemicals and Botanical Products
- IART Medical/Dental Instruments
- Sector
- SANA Health Care
- IART Health Care
- Exchange
- SANA Nasdaq
- IART Nasdaq
- Market Cap
- SANA 983.4M
- IART 978.4M
- IPO Year
- SANA 2021
- IART 1995
- Fundamental
- Price
- SANA $3.91
- IART $12.31
- Analyst Decision
- SANA Strong Buy
- IART Hold
- Analyst Count
- SANA 6
- IART 8
- Target Price
- SANA $10.00
- IART $18.17
- AVG Volume (30 Days)
- SANA 5.5M
- IART 1.1M
- Earning Date
- SANA 08-11-2025
- IART 07-31-2025
- Dividend Yield
- SANA N/A
- IART N/A
- EPS Growth
- SANA N/A
- IART N/A
- EPS
- SANA N/A
- IART N/A
- Revenue
- SANA N/A
- IART $1,621,738,000.00
- Revenue This Year
- SANA N/A
- IART $5.56
- Revenue Next Year
- SANA N/A
- IART $4.41
- P/E Ratio
- SANA N/A
- IART N/A
- Revenue Growth
- SANA N/A
- IART 3.53
- 52 Week Low
- SANA $1.26
- IART $11.06
- 52 Week High
- SANA $7.30
- IART $27.13
- Technical
- Relative Strength Index (RSI)
- SANA 47.52
- IART 47.35
- Support Level
- SANA $4.72
- IART $12.27
- Resistance Level
- SANA $5.33
- IART $14.07
- Average True Range (ATR)
- SANA 0.35
- IART 0.66
- MACD
- SANA -0.14
- IART 0.07
- Stochastic Oscillator
- SANA 3.40
- IART 41.14
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.